The 30010 Dry Powder Insufflator is a hand-operated, pulmonary drug delivery device.
It is designed to produce a cloud of fine particles from the end of a small-diameter delivery tube.It can be used to aerosolize and administer a precise dose of dry powder to the lungs, nasal cavities or other invitro applications.
It has a hollow stainless steel tip with a 120-degree bend that helps keep the user’s hand out of the line of sight, making it easier to view the epiglottis.
The atomization transmission module of this device is sterilizable and reusable.Our Dry Powder Insufflator is a precision preclinical pulmonary drug delivery device designed for dry powder formulation administration to small animals (mice, rats, guinea pigs). It delivers quantitative dry powder directly into the trachea and deep lung, achieving repeatable lung deposition for respiratory drug evaluation.
Additionally, it can be applied to exploratory nose-to-brain drug delivery research, with customizable dosing calibration, needle lengths and supporting auxiliary devices to meet the experimental needs of different animal models.No compressed air source required. The mechanical design avoids sample denaturation; it is ideal for dry powder drugs, inhaled peptides, proteins, antibiotics, dry powder vaccines and microparticle formulations. It eliminates complicated aerosol generation equipment, greatly simplifies in-vivo pulmonary pharmacology, lung toxicity and respiratory infection model studies.
✅ Customizable Dosing for Multiple Animals
We support personalized dose calibration to match mice, rats, guinea pigs and other small animal models, ensuring accurate and species-specific pulmonary delivery.
✅ Adjustable Needle Length Options
Custom intubation needle lengths are available to fit different animal airway depths, improving tracheal insertion accuracy and maximizing lung deposition efficiency.
✅ Complete Auxiliary Supporting System
Custom supporting auxiliary devices can be configured according to your experimental protocol, including animal fixing holders, positioning brackets and dosing assisting tools to standardize your operation workflow.
✅ Pure Mechanical & Compressor-Free Design
No air pressure impact, no thermal damage. Fully protects the activity of dry powder APIs, inhaled peptides, microparticles, and dry powder vaccines.
✅ Low Dead Volume & Cross-Contamination Prevention
Replaceable tips + stable quantitative delivery ensure consistent, repeatable data for high-standard preclinical pharmacology, toxicology and vaccine evaluation studies.
1. Introduction
Dry Powder Insufflator Model 30010 specifications:
- Based on stainless steel, thin-wall needle tubing with an outer diameter (o.d.) of 1.00mm
- Single atomization powder mass: 1-10 mg(if the Sample density =1)
- Single aerosol generation:0.5-5ml
- Particle size: More than 90% of particle under 5 microns (ISO12103A2 sample test)
2. Dry Powder Insufflator--Application
Dry Powder Insufflator can be used in many fields, such as inhalation toxicology, aerobiology, biological hazard testing, inhalation immunity, inhalation therapy, drug research, environmental research, environmental assessment, biological, chemical hazard assessment and medical protection.
a. Investigation of pulmonary absorption mechanisms
By administering labeled dry powder drugs, the absorption and transport processes of the drug in alveoli and pulmonary interstitium can be observed, and the absorption rates and extent of drug uptake at different sites such as alveoli and pulmonary interstitium can be accurately determined, thereby establishing a reliable drug absorption model.
b. Analysis of pulmonary metabolic processes
The pulmonary dry powder administration technique enables the detection of drug metabolite formation and changes in the lungs post-administration, facilitating analysis of pulmonary metabolic enzyme activity and metabolic pathways. It also allows assessment of pharmacokinetic parameters in the lungs, including metabolic rates, metabolite formation, and clearance.
c. Assessment of pulmonary clearance mechanisms
Dry powder administration to the lungs can act directly on pulmonary tissues, and studies have investigated the effects of alveolar macrophages, pulmonary surfactant, and ciliary motility on drug clearance.
d. Investigate pulmonary immune responses and barrier functions
By administering pulmonary dry powder containing immune stimulants, the activation of pulmonary immune cells and inflammatory responses can be observed. The use of labeled particles or macromolecules as probes enables evaluation of the regulatory role of barrier structures such as pulmonary vascular endothelium and epithelium in substance permeability.
e. Establish a pharmacokinetic model for pulmonary-systemic circulationBased on pulmonary dry powder administration data, a detailed pharmacokinetic model of the lung-plasma-systemic circulation can be established to more accurately predict the drug's absorption, distribution, metabolism, and elimination processes in vivo.
f.Exploratory Nose-to-Brain (N2B) Delivery Research
This device is available for exploratory nose-to-brain research, capable of delivering dry powder formulations to the nasal olfactory region to bypass the blood-brain barrier. It is suitable for preclinical exploratory studies on neurodegenerative diseases, neuroprotective agents, peptide drugs, siRNA and brain-targeted therapeutics, supporting researchers in exploring innovative CNS drug delivery approaches.
3. Other Product Recommendations
The appropriate tools can significantly enhance your workflowefficiency. The endotracheal intubation table and smallanimal larngoscope serveas essential aids for performing pulmonary drug administration procedures, and are recommended to be used in conjunction with a pulmonary dry powder nebulizer.
a. Tracheal Intubation Platform
This sytem supports small animals such as mice and rats in maintaining a stable and comfortable position for tracheal intubation, drug perfusion, and other similar experinental procedures. t alows fixation at various puncture sites as required and enables adustment of mutiple operational angles to meet the demands of diferentexperimental types and animal species.

b. SR-309 Small Animal Laryngos
Used for observing structures such as the larynx in experimental animals, facilitating procedures like pulmonary drug administrationand transoral endotracheal intubation. Suitable for mice, rats, and guinea pigs, and can be customized according to specific requirements.
The LED lighting system provides clear and bright illumination, offeringimproved visibility for operators examining structures such as thelarynx and epiglottis. The front end features a stainless steel blade tipthat can be easily removed or replaced. The handle design adheres toergonomic principles, ensuring comfortable and convenient operation.